25 May 2013
Keywords: alza, acquires, marketing, distribution, rights, urispas, acquired
Article | 05 November 1998
Alza has acquired the US marketing and distribution rights toUrispas (flavoxate hydrochloride) from SmithKline Beecham. Alza is to
pay SB ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
24 May 2013
© 2013 thepharmaletter.com